Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model
- 1 December 2002
- Vol. 20, A52-A60
- https://doi.org/10.1016/s0264-410x(02)00388-2
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced Patients with Advanced HIV DiseaseAIDS Research and Human Retroviruses, 2002
- Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2001
- Differential Expression of Interleukin-2 and Gamma Interferon in Human Immunodeficiency Virus DiseaseJournal of Virology, 2001
- Preferential S Phase Entry and Apoptosis of CD4+ T Lymphocytes of HIV-1-Infected Patients after in Vitro CultivationClinical Immunology, 2000
- Circulating Levels andex VivoProduction of β-Chemokines, Interferon γ, and Interleukin 2 in Advanced Human Immunodeficiency Virus Type 1 Infection: The Effect of Protease Inhibitor TherapyAIDS Research and Human Retroviruses, 2000
- Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in ChildrenThe Journal of Infectious Diseases, 1999
- Comparison between subcutaneous and intravenous interleukin‐2 treatment in HIV diseaseJournal of Internal Medicine, 1998
- Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.Journal of Clinical Investigation, 1997
- Early Postinfection Antiviral Treatment Reduces Viral Load and Prevents CD4+Cell Decline in HIV Type 2-Infected MacaquesAIDS Research and Human Retroviruses, 1997
- Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infectionClinical and Experimental Immunology, 1990